Comparison between 6pLOH(+) and 6pLOH(−) patients
. | 6pLOH(+) . | 6pLOH(−) . | P . |
---|---|---|---|
Number of patients | 43 | 181 | |
Age, median years (range) | 69 (18-82) | 64 (15-90) | .27 |
Sex | |||
Male | 21 | 73 | .39 |
Female | 22 | 108 | |
Severity | |||
Severe | 22 | 60 | .03 |
Nonsevere | 21 | 121 | |
Prior IST | |||
ATG/CsA | 5 | 12 | .44 |
CsA | 6 | 22 | |
None | 32 | 147 | |
HLA-B*40:02 | |||
(+) | 25 | 49 | .0002 |
(−) | 18 | 132 | |
HLA-DRB1*08:02 | |||
(+) | 8 | 12 | .03 |
(−) | 35 | 169 | |
HLA-A*02:01 | |||
(+) | 11 | 43 | .84 |
(−) | 32 | 138 | |
HLA-A*02:06 | |||
(+) | 7 | 45 | .32 |
(−) | 36 | 136 | |
HLA-A*31:01 | |||
(+) | 8 | 43 | .55 |
(−) | 35 | 138 |
. | 6pLOH(+) . | 6pLOH(−) . | P . |
---|---|---|---|
Number of patients | 43 | 181 | |
Age, median years (range) | 69 (18-82) | 64 (15-90) | .27 |
Sex | |||
Male | 21 | 73 | .39 |
Female | 22 | 108 | |
Severity | |||
Severe | 22 | 60 | .03 |
Nonsevere | 21 | 121 | |
Prior IST | |||
ATG/CsA | 5 | 12 | .44 |
CsA | 6 | 22 | |
None | 32 | 147 | |
HLA-B*40:02 | |||
(+) | 25 | 49 | .0002 |
(−) | 18 | 132 | |
HLA-DRB1*08:02 | |||
(+) | 8 | 12 | .03 |
(−) | 35 | 169 | |
HLA-A*02:01 | |||
(+) | 11 | 43 | .84 |
(−) | 32 | 138 | |
HLA-A*02:06 | |||
(+) | 7 | 45 | .32 |
(−) | 36 | 136 | |
HLA-A*31:01 | |||
(+) | 8 | 43 | .55 |
(−) | 35 | 138 |